Cagri 5mg
Cagrilintide (often shortened to Cagri) is a long-acting analog of amylin, a hormone that’s naturally released alongside insulin after you eat. It is being studied and used (in some countries/investigational settings) primarily for weight management, often in combination with GLP-1 medications.
Its main effects include:
- Reduces appetite by signaling fullness to the brain.
- Slows stomach emptying, helping you feel full longer after meals.
- May enhance weight loss when combined with a GLP-1 medication such as semaglutide, as the two work through different pathways.
- May help improve blood sugar control, though its primary focus is weight reduction.
Common side effects are similar to GLP-1 medications and can include nausea, vomiting, constipation, diarrhea, and decreased appetite, especially when first starting or increasing the dose.
In short: Cagrilintide is used to help people eat less by increasing satiety, and it has shown promising results for significant weight loss, particularly when paired with a GLP-1 medication.